Published in J Antimicrob Chemother on January 01, 2008
Spectrum of zygomycete species identified in clinically significant specimens in the United States. J Clin Microbiol (2009) 2.02
Detection of a Serum Siderophore by LC-MS/MS as a Potential Biomarker of Invasive Aspergillosis. PLoS One (2016) 1.40
Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers. Antimicrob Agents Chemother (2009) 1.28
Sporangiospore size dimorphism is linked to virulence of Mucor circinelloides. PLoS Pathog (2011) 1.26
Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae. Antimicrob Agents Chemother (2008) 1.18
Mucor circinelloides as a cause of invasive maxillofacial zygomycosis: an emerging dimorphic pathogen with reduced susceptibility to posaconazole. J Clin Microbiol (2009) 1.04
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection. Antimicrob Agents Chemother (2009) 1.00
Successful treatment of a case with rhino-orbital-cerebral mucormycosis by the combination of neurosurgical intervention and the sequential use of amphotericin B and posaconazole. J Korean Neurosurg Soc (2010) 1.00
High-throughput identification and quantification of Candida species using high resolution derivative melt analysis of panfungal amplicons. J Mol Diagn (2009) 0.99
Evaluation of Luminex xTAG fungal analyte-specific reagents for rapid identification of clinically relevant fungi. J Clin Microbiol (2011) 0.93
Rapamycin exerts antifungal activity in vitro and in vivo against Mucor circinelloides via FKBP12-dependent inhibition of Tor. Eukaryot Cell (2011) 0.92
Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice. Antimicrob Agents Chemother (2010) 0.87
Mixed fungal infection (Aspergillus, mucor, and Candida) of severe hand injury. Case Rep Infect Dis (2014) 0.87
Variability analyses of functional domains within glucosamine-6-phosphate synthase of mycosescausing fungi. Bioinformation (2011) 0.86
The rise of an opportunistic infection called "Invasive Zygomycosis". J Glob Infect Dis (2009) 0.84
Subcutaneous zygomycosis caused by Mucor hiemalis in an immunocompetent patient. Australas Med J (2013) 0.83
In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella. Antimicrob Agents Chemother (2010) 0.79
Efficacy of liposomal amphotericin B combined with gamma interferon or granulocyte-macrophage colony-stimulating factor for treatment of systemic zygomycosis in mice. Antimicrob Agents Chemother (2009) 0.79
Zygomycetes peritonitis in ambulatory peritoneal dialysis: Case report and review of literature. Indian J Nephrol (2014) 0.79
Rhizomucor and scedosporium infection post hematopoietic stem-cell transplant. Case Rep Med (2011) 0.78
Mycotic pseudoaneurysms complicating renal transplantation: a case series and review of literature. J Med Case Rep (2012) 0.78
Mucormycosis of pouch of douglas in a diabetic woman. J Glob Infect Dis (2012) 0.78
Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study. BMC Infect Dis (2016) 0.77
Pharmacologic and clinical evaluation of posaconazole. Expert Rev Clin Pharmacol (2015) 0.77
Pulmonary mucormycosis complicating cutaneous blastic plasmacytoid dendritic cell neoplasm. Proc (Bayl Univ Med Cent) (2012) 0.76
Mortierella wolfii-associated invasive disease. Emerg Infect Dis (2014) 0.75